Join Thomas Powles, MBBS, MRCP, MD, Andrea Necchi, MD, and Cora N. Sternberg, MD, FACP in a discussion on the role of immunotherapy in urotherlial carcinoma.

This educational activity is intended for an international audience of non-US hematologists/oncologists and urologists. The goal of this activity is to increase oncologists' and urologists' understanding of the role of immunotherapy in the treatment of locally advanced or metastatic urothelial carcinoma.
 

Learning Objectives:

Upon completion of this activity, participants will:

• Have increased knowledge regarding the
  • Available immunotherapy strategies for locally advanced/metastatic urothelial carcinoma
  • Supporting evidence for immunotherapy strategies for locally advanced/metastatic urothelial carcinoma
• Have greater competence related to
  • Selecting the right immunotherapy strategy for the right patient with locally advanced/metastatic urothelial carcinoma

Approximate Time to Complete: 30 minutes

Credit Available: March 11, 2022 - March 11, 2023

Developed through a partnership between SITC and Medscape.

Additional Resources for Clinicans from SITC: